BioSpace News Archive

Florida Cancer Specialists & Research Institute, LLC announced that Lucio Gordan, MD has assumed the role of President & Managing Physician, effective January 16, 2023.

The nation’s leading ophthalmic surgeons find the ZEPTO IOL Positioning System™ from Centricity Vision Inc. improves the precision and efficiency of cataract surgery, while enabling the growing trend of office-based surgeries preferred for patient comfort and convenience.

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Invitation to attend XVIVO’s conference call regarding the presentation of the Report on operations 2022.

BioMed X, an independent German biomedical research institute, announced today the extension of its ongoing research collaboration with AbbVie.

argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced an extraordinary general meeting of shareholders will be held at 12:00 PM CET on Monday, February 27, 2023 at the Hilton Amsterdam Schiphol at Schiphol Boulevard 701, 1118 BN Schiphol, the Netherlands.

OBiO Technology (Shanghai) Corp., Ltd. (‘OBiO’, 688238.SH), a gene and cell therapy-focused contract research organization (CRO) and contract development and manufacturing organization (CDMO), recently announced that the United States Food and Drug Administration (FDA) has accepted its GMP plasmid DNA drug master file (DMF), DMF Number 037766.

Ascletis Pharma Inc. (HKEX: 1672, “Ascletis”) today announces that its wholly owned subsidiary Ascletis Pharmaceuticals Co., Ltd. has entered into a supply agreement of ritonavir tablets with Hainan Simcere Pharmaceutical Co., Ltd., a subsidiary of Simcere Pharmaceutical Group Limited (HKEX: 2096, “Simcere”).

Takeda announced that, for the sixth consecutive year, it was one of only 15 companies to achieve global Top Employer® certification for 2023.

Calibre Scientific is pleased to announce the acquisition of Glass Chemicals, a Spanish distributor of scientific consumables, equipment and services for the life sciences, diagnostics, and industrial sectors.

Juvenescence has named Dr Richard Marshall CBE as its new CEO, effective 16 January 2023.